This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma’s LUCID-MS program is built around the unmet need for MS therapies capable of ...
The FDA has placed a clinical hold on Quantum’s application seeking clearance to begin a Phase 2 trial testing Lucid-MS in ...
Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...
ScienceAlert on MSN
Promising Anti-Aging Drug May Cause Brain Damage, Scientists Warn
(Brad Wenner/Moment/Getty Images) The experimental drug combo dasatinib and quercetin (known for short as D+Q) is one of the ...
The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Tau protein levels are lower in more highly myelinated cortical regions. Tau spreading ...
New evidence of myelin's essential role in learning and retaining new practical skills, such as playing a musical instrument, has been uncovered by research. Myelin is a fatty substance produced by ...
Tested as a possible brain therapy, the anti-aging drug combo instead stripped nerve insulation from mice, and the youngest ...
Quantum BioPharma's LUCID-MS program is built around the unmet need for MS therapies capable of directly protecting or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results